The Journal of the Korean Rheumatism Association 2007; 14(1): 23-30
Published online March 30, 2007
© Korean College of Rheumatology
박미경·박성환·곽승기·조미라·김호연
가톨릭대학교 의과학연구원 류마티스연구센터
Correspondence to : Sung-Hwan Park
Objective: Epigenetics is an important, alternative mechanism of gene regulation that is independent of the nucleotide sequences of DNA. We investigated mRNA levels for DNA methyltransferase-1 (DNMT-1), and the effect of estrogen on the expression of DNMT-1 level in T cells and B cells from patients with systemic lupus erythematosus (SLE) and healthy subjects, and assessed the possible etiological role of DNA methylation in the pathogenesis of SLE. Methods: mRNA levels for DNMT-1 in CD4 T cells and CD19 B cells from 37 patients with SLE and 12 healthy controls were examined using RT-PCR. We used specific primer for DNMT-1 and β actin, The effect of estrogen on the DNA methylation was measured by the mRNA level of DNMT-1 CD4 T cells and CD19 B cells treated with 100 nM of 17β-estradiol for 72 hour. Results: The levels of DNMT-1 mRNA were significantly lower in CD4 T cells and CD19 B cells from SLE patients compared with healthy controls. We observed the suppression of the levels of DNMT-1 mRNA by stimulated with estrogen in patients with SLE patients, especially in CD19B cells. DNA hypomethylation of B cells was tend to be correlated with the level of anti-ds DNA antibody without statistical significance (r=0.43, p=0.3). Conclusion: Our observations suggest that suppression of DNMT-1 by estrogen in B cells from patients with SLE might be related to the pathogenesis of SLE. Epigenetic studies may provide clues for developing new treatment strategies of SLE.
Keywords Systemic lupus erythematosus, DNA methyltransferase-1, DNA methylation, Estrogen
The Journal of the Korean Rheumatism Association 2007; 14(1): 23-30
Published online March 30, 2007
Copyright © Korean College of Rheumatology.
박미경·박성환·곽승기·조미라·김호연
가톨릭대학교 의과학연구원 류마티스연구센터
Mi-Kyung Park, B.S., Sung-Hwan Park, M.D., Seung-Ki Kwok, M.D., Mi-La Cho, Ph.D., Ho-Youn Kim, M.D.
The Rheumatism Research Center (RhRC), Catholic Research Institute of Medical Science, The Catholic University of Korea, Seoul, Korea
Correspondence to:Sung-Hwan Park
Objective: Epigenetics is an important, alternative mechanism of gene regulation that is independent of the nucleotide sequences of DNA. We investigated mRNA levels for DNA methyltransferase-1 (DNMT-1), and the effect of estrogen on the expression of DNMT-1 level in T cells and B cells from patients with systemic lupus erythematosus (SLE) and healthy subjects, and assessed the possible etiological role of DNA methylation in the pathogenesis of SLE. Methods: mRNA levels for DNMT-1 in CD4 T cells and CD19 B cells from 37 patients with SLE and 12 healthy controls were examined using RT-PCR. We used specific primer for DNMT-1 and β actin, The effect of estrogen on the DNA methylation was measured by the mRNA level of DNMT-1 CD4 T cells and CD19 B cells treated with 100 nM of 17β-estradiol for 72 hour. Results: The levels of DNMT-1 mRNA were significantly lower in CD4 T cells and CD19 B cells from SLE patients compared with healthy controls. We observed the suppression of the levels of DNMT-1 mRNA by stimulated with estrogen in patients with SLE patients, especially in CD19B cells. DNA hypomethylation of B cells was tend to be correlated with the level of anti-ds DNA antibody without statistical significance (r=0.43, p=0.3). Conclusion: Our observations suggest that suppression of DNMT-1 by estrogen in B cells from patients with SLE might be related to the pathogenesis of SLE. Epigenetic studies may provide clues for developing new treatment strategies of SLE.
Keywords: Systemic lupus erythematosus, DNA methyltransferase-1, DNA methylation, Estrogen
Bong-Woo Lee, M.D., Eui-Jong Kwon, M.D., Ji Hyeon Ju, M.D., Ph.D.
J Rheum Dis -0001; ():So-Young Bang, M.D., Ph.D., Seung Cheol Shim, M.D., Ph.D.
J Rheum Dis 2024; 31(4): 200-211Alhanouf Adnan Alsharif, M.B.B.S., Abdulaziz Marzouq Almutairi, M.D., Emtenan Badar Basahl, M.B.B.S., Abdulaziz Abdulllah Alshathri, M.D., Jameela Abdulaziz Kari, M.D., Mohammed Ahmad Shalaby, M.D., Mohammed Ahmad Nashawi, M.D.
J Rheum Dis 2025; 32(1): 57-62